• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TGFbeta Regulation of Osteopontin Gene Expression

Research Project

Project/Area Number 04454372
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Orthopaedic surgery
Research InstitutionTokyo Medical and Dental University

Principal Investigator

OGATA Toshiko  Tokyo medical & Dental University, Medical Research Institute, Assistant Professor, 難治疾患研究所, 助手 (80014314)

Co-Investigator(Kenkyū-buntansha) 野田 政樹  東京医科歯科大学, 難治疾患研究所, 教授 (50231725)
二藤 彰  東京医科歯科大学, 難治疾患研究所, 助手 (00240747)
川口 奈奈子  東京医科歯科大学, 難治疾患研究所, 助手 (10200700)
Project Period (FY) 1992 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥6,900,000 (Direct Cost: ¥6,900,000)
Fiscal Year 1993: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1992: ¥6,100,000 (Direct Cost: ¥6,100,000)
Keywordsosteopontin / gene / promoter / chloramphenicolacetyltransferase / DEAE-dextran / transfection
Research Abstract

We investigated the effect of TGFbeta on the expression of osteopontin gene. To do this, about 1,000bp of the promoter region of the mouse osteopontin gene was cloned and this fragment was used to construct a vector containing a reporter gene, chloramphenicol acetyl transferase (CAT). Three deletion constructs containing -777/+79, -545/+79, -253/+79, promoter fragments were also constructed. These reporter constructs were then transfected into osteoblastic osteosarcoma ROS17/2.8 cells. As osteoblastic cells, MC3T3E1, another type of cell line was also used. The latter cells were representing non-transformed class of cells with capability to induce bone formation in vitro and to form calcified nodules. For transfection, either DEAE-transfection or electroporation was found to be effective to introduce these gene constructs into the two types osteoblasts. The expression of CAT and its activity was measured to estimate the activity of the promoter and its fragments. The difference of the promoter activiy varied several fold among the constructs with varying length of the promoter. After the tansfection was completed, the cells were subsequently treated with TGF-beta1 for up tp 72 hours. The effect of the TGFbeta1 was found to be stimulatory in all the constructs examined in this study. We concluded that TGFbeta1 acts on the relatively short fragment downstream of the nucleotide position -253. In this region several consensus sites for known transcription regulators were located. Among those, E-box sequences (CANNTG) would be a candidate for the osteoblastic expression and regulation of osteopontin gene, since expression of transcription regulators with helix-loop-helix motif was found to be under the control of calcitropic regulators such as bone morphegenetic protein, which is a member of TGFbeta family, as well as calcitriol and dexamethasone. We would like to further define elements responsible for TGFbeta regulation of osteopontin gene expression.

Report

(3 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Toshiko Ogata,John M.Wozney,G.A.Rodan,Masaki Noda: "Bone morphogenetic protein-2(BMP-2)acts both synergistically with and artagonistically against retinoic acid in regulating expression of phenotypic genes osteoblast-like cells." Endocrine Journal. 9(in press). (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Toshiko Ogata,John M.Wozney,R.Benezra,Masaki Noda: "Bone morphogenetic protein-2 enhances expression of a gene,Id(Inhibitor of Differentiation),encoding a helix-loop-helix molecule in osteoblast-like cells." Proceedings of the National Academy of Science,U.S.A.90. 9219-9222 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Toshio Ogata, John M.Wozney, G.A.Rodan, Masaki Noda: "Bone morphogenetic protein-2 (BMP-2) acts both synergistically with and antagonistically against retinoic acid in regulating expresion of pherotypic genes osteoblast-like cells." Endocrine Journal. 9 in presss. (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Toshio Ogata, John M.Wozney, R.Benezra, Masaki Noda: "Bone morphogenetic protein-2 enhances expression of a gene, Id(Inhibitor of Differentiation), encoding a halix-loop-helix molecule in osteoblast-like cells." Proceeding of the National Academy of Science, U.S.A.90. 9219-9222 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Toshiko Ogata,John M.Wozney,G.A.Rodan,Masaki Noda: "Bone morphogenetic protein-2(BMP-2)acts both synergistically with and antagonistically against retiroic acidin regulating expression of phenotypic genes osteoblast-like cells." Endocrine Journal. 9 (in press). (1994)

    • Related Report
      1993 Annual Research Report
  • [Publications] Toshiko Ogata,John M.Wozney,R.Benezre,Masaki Noda: "Bone morphogenetic protein-2 enhances expression of agene,Id(Inhibitor of Differentiation),ercoding a helix-loop-helix molecule in osteoblast-like cells." Proceedings of the National Academy of Science,U.S.A.90. 9219-9222 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Ogata T,Wozney J,Benezro R,Deluca H.F,and Noda M: "A differentiation-promoting factor,Bone Morphogenetic Protein-2,Enhances Expression of a Helix-Loop-Helix Molecule,Id(Inhibitor of Differentiation)in Proliferating Osteoblast-like cells." Proc.Natl.Acad.Sci.U.S.A.90. (1993)

    • Related Report
      1992 Annual Research Report

URL: 

Published: 1992-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi